<html><head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
</head><body>
<span style="position:absolute; border: gray 1px solid; left:0px; top:50px; width:612px; height:792px;"></span>
<div style="position:absolute; top:50px;"><a name="1">Page 1</a></div>
<div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:106px; width:500px; height:669px;"><span style="font-family: Arial,Italic; font-size:6px">3</span><span style="font-family: Arial,Italic; font-size:10px">Department of Biostatistics, New Bolton Center, School of Veterinary Medicine, University of 
<br>Pennsylvania, Philadelphia, PA;  
<br></span><span style="font-family: Arial,Italic; font-size:6px">4</span><span style="font-family: Arial,Italic; font-size:10px">Clinical Research Unit, University of Alabama at Birmingham, Birmingham, AL;  
<br></span><span style="font-family: Arial,Italic; font-size:6px">5</span><span style="font-family: Arial,Italic; font-size:10px">Division of Endocrinology and Metabolism, Department of Medicine, University of Alabama at 
<br>Birmingham, Birmingham, AL;  
<br></span><span style="font-family: Arial,Italic; font-size:6px">6</span><span style="font-family: Arial,Italic; font-size:10px">Department of Human Studies, University of Alabama at Birmingham, Birmingham, AL;  
<br></span><span style="font-family: Arial,Italic; font-size:6px">7</span><span style="font-family: Arial,Italic; font-size:10px">Ingredion Inc., Bridgewater, NJ. 
<br>Email: bgower@uab.edu 
<br></span><span style="font-family: Arial; font-size:7px"> 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Objective:</span><span style="font-family: Arial; font-size:10px"> This study was designed to examine the effect of HAM-RS2 resistant starch on insulin 
<br>sensitivity in women. 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Methods:</span><span style="font-family: Arial; font-size:10px"> Participants were 40 healthy pre- and postmenopausal women.  The study was conducted 
<br>using a randomized, placebo-controlled, double-blind cross-over design.  HAM-RS2 (HI-MAIZE</span><span style="font-family: Arial; font-size:6px">®</span><span style="font-family: Arial; font-size:10px">260 
<br>corn starch, Ingredion Incorporated, Bridgewater, NJ) was formulated into snack foods and tested at 
<br>two doses, 15 and 30 g resistant starch per day.  An isocaloric snack formulated with a highly-
<br>digestible waxy corn starch served as a control.  Each arm was 4 weeks, with a 4-week wash-out 
<br>period between.  The main outcome was insulin sensitivity (S</span><span style="font-family: Arial; font-size:6px">I</span><span style="font-family: Arial; font-size:10px">) assessed at the end of each arm by 
<br>Minimal Model.  Data were analyzed by mixed-effects modeling, adjusting for covariates. 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Results:</span><span style="font-family: Arial; font-size:10px"> Two Gaussian distributions for S</span><span style="font-family: Arial; font-size:6px">I</span><span style="font-family: Arial; font-size:10px"> were identified, an insulin-resistant (IR) group (S</span><span style="font-family: Arial; font-size:6px">I</span><span style="font-family: Arial; font-size:10px">&lt;7.8), and 
<br>an insulin-sensitive (IS) group (S</span><span style="font-family: Arial; font-size:6px">I</span><span style="font-family: Arial; font-size:10px">&gt;7.8).  Among IR participants, S</span><span style="font-family: Arial; font-size:6px">I</span><span style="font-family: Arial; font-size:10px"> was on average 16% higher after 
<br>the 30 g supplement when compared to the control (P=0.02). No effect of HAM-RS2 on insulin 
<br>sensitivity was observed among IS participants. 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Conclusions:</span><span style="font-family: Arial; font-size:10px">  Among insulin-resistant women, consumption of 30 g/d HAM-RS2 improved insulin 
<br>sensitivity by 16%.  Because insulin resistance is a risk factor for diabetes, HAM-RS2 may be an 
<br>appropriate dietary ingredient to reduce risk for diabetes in insulin-resistant</span><span style="font-family: Arial; font-size:11px"> women. 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Protocol registration:</span><span style="font-family: Arial; font-size:10px"> NCT0152806 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Funding source:</span><span style="font-family: Arial; font-size:10px"> Ingredion Incorporated, P30DK56336, P60DK079626, UL1RR025777 
<br></span><span style="font-family: Times New Roman; font-size:10px"> 
<br></span><span style="font-family: Arial; font-size:11px"> 
<br></span><span style="font-family: Arial,Bold; font-size:11px">Oral Abstract 8 – Linking microbial consumption of resistant starch to 
<br>functional outcomes</span><span style="font-family: Arial; font-size:11px">  
<br></span><span style="font-family: Arial,Bold; font-size:11px">(Maria Marco, USA) 
<br></span><span style="font-family: Arial; font-size:6px"> 
<br></span><span style="font-family: Arial; font-size:10px">Intestinal microorganisms have important beneficial roles in the regulation of energy homeostasis, lipid 
<br>and glucose metabolism, and the immune system. Conversely, a dysbiotic gut microbiota is 
<br>associated with obesity, type 2 diabetes mellitus, and metabolic syndrome. Therefore, dietary 
<br>approaches to modulate the composition and activities of the gut microbiota might be sufficient to 
<br>protect and alleviate the symptoms against these chronic diseases. This presentation will describe 
<br>recent highlights in the progress to unravel how dietary fermentable carbohydrates such as type 2 
<br></span><span style="font-family: Arial; font-size:10px">resistant starch (RS) improve metabolic health. Specifically, findings from human and murine studies 
<br></span><span style="font-family: Arial; font-size:10px">will presented with regard to the specific bacterial groups enriched with RS consumption and the 
<br></span><span style="font-family: Arial; font-size:10px">impact of RS on the intestinal and serum metabolomes and gene expression in the intestine as well as 
<br></span><span style="font-family: Arial; font-size:10px">distal sites in the body. 
<br> 
<br></span><span style="font-family: Arial; font-size:10px"> 
<br> 
<br></span><span style="font-family: Arial; font-size:10px"> 
<br></span><span style="font-family: Arial; font-size:10px"> 
<br></span><span style="font-family: Arial; font-size:10px"> 
<br> 
<br> 
<br> 
<br> 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:781px; width:13px; height:24px;"><span style="font-family: ABCDEE+Calibri; font-size:11px">50 
<br> 
<br></span></div><span style="position:absolute; border: black 1px solid; left:90px; top:206px; width:86px; height:0px;"></span>
<span style="position:absolute; border: black 1px solid; left:217px; top:354px; width:6px; height:0px;"></span>
<div style="position:absolute; top:0px;">Page: <a href="#1">1</a></div>
</body></html>
